| 000 | 01025nam a2200193Ia 4500 | ||
|---|---|---|---|
| 020 | _a8189023322 | ||
| 082 |
_a338.473621 _bGUE |
||
| 100 |
_aGuennif, Samira _912659 |
||
| 245 |
_aTRIPS plus agreements and issues in access to medicines in developing countries. _hBook |
||
| 260 |
_aAhmedabad _bGujarat Inst. of Devp. Research _c2006 |
||
| 300 | _aii,ii,20p. | ||
| 440 |
_aGIDR working paper _vNo.174 _942101 |
||
| 500 | _aAbstracti Acknowledgement i Contents ii List of Tablesii 1. Introduction 1 2. Flexibilities Provided by the TRIPS Agreement 1 3. The Doha Declaration4 4. Thailand Experience 5 5. Free Trade Agreements : Accessibility of Drugs under Higher Standards 7 5.1 Objectives and purpose of FTA 8 5.2. The Provisions Incriminated 10 5.2.1Criteria of Patentability 10 5.2.2 Patent Territory 11 5.2.3 Patent Duration12 5.2.4 Disclosure of Clinical Data 12 6. Conclusion 17 Reference 18 | ||
| 600 | _942511 | ||
| 700 |
_aLalitha, N. _942512 |
||
| 890 | _aIndia | ||
| 891 | _aFP | ||
| 942 | _2ddc | ||
| 999 |
_c35322 _d35322 |
||